Cargando…

Ecological networking of cystic fibrosis lung infections

In the context of a polymicrobial infection, treating a specific pathogen poses challenges because of unknown consequences on other members of the community. The presence of ecological interactions between microbes can change their physiology and response to treatment. For example, in the cystic fib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quinn, Robert A, Whiteson, Katrine, Lim, Yan Wei, Zhao, Jiangchao, Conrad, Douglas, LiPuma, John J, Rohwer, Forest, Widder, Stefanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460249/ https://www.ncbi.nlm.nih.gov/pubmed/28649398 http://dx.doi.org/10.1038/s41522-016-0002-1

Ejemplares similares

Biogeochemical Forces Shape the Composition and Physiology of Polymicrobial Communities in the Cystic Fibrosis Lung
por: Quinn, Robert A., et al.
Publicado: (2014)

Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease
por: Quinn, Robert A., et al.
Publicado: (2016)

Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome
por: Quinn, Robert A, et al.
Publicado: (2016)

Breath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2,3-butanedione fermentation
por: Whiteson, Katrine L, et al.
Publicado: (2014)

Making It Last: Storage Time and Temperature Have Differential Impacts on Metabolite Profiles of Airway Samples from Cystic Fibrosis Patients
por: Wandro, Stephen, et al.
Publicado: (2017)

Mucus Distribution Model in a Lung with Cystic Fibrosis
por: Zarei, Sara, et al.
Publicado: (2012)

The Microbiome in Cystic Fibrosis
por: Huang, Yvonne J., et al.
Publicado: (2016)

Metagenomic Analysis of Respiratory Tract DNA Viral Communities in Cystic Fibrosis and Non-Cystic Fibrosis Individuals
por: Willner, Dana, et al.
Publicado: (2009)

Draft Genome Sequences of 63 Pseudomonas aeruginosa Isolates Recovered from Cystic Fibrosis Sputum
por: Spilker, Theodore, et al.
Publicado: (2016)

Impact of Enhanced Staphylococcus DNA Extraction on Microbial Community Measures in Cystic Fibrosis Sputum
por: Zhao, Jiangchao, et al.
Publicado: (2012)

Longitudinal Microbial and Molecular Dynamics in the Cystic Fibrosis Lung after Elexacaftor-Tezacaftor-Ivacaftor therapy
por: Martin, Christian, et al.
Publicado: (2023)

Cystic Fibrosis Rapid Response: Translating Multi-omics Data into Clinically Relevant Information
por: Cobián Güemes, Ana Georgina, et al.
Publicado: (2019)

Multi-Omics Study of Keystone Species in a Cystic Fibrosis Microbiome
por: Silveira, Cynthia B., et al.
Publicado: (2021)

The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
por: Carmody, Lisa A, et al.
Publicado: (2015)

Infection by Ralstonia Species in Cystic Fibrosis Patients: Identification of R. pickettii and R. mannitolilytica by Polymerase Chain Reaction
por: Coenye, Tom, et al.
Publicado: (2002)

Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection
por: Caverly, Lindsay J., et al.
Publicado: (2021)

Cystic Fibrosis Mice Develop Spontaneous Chronic Bordetella Airway Infections
por: Darrah, R, et al.
Publicado: (2017)

Microbial Metabolites in Cystic Fibrosis: A Target for Future Therapy?
por: Widder, Stefanie, et al.
Publicado: (2019)

Molecular and Microbial Microenvironments in Chronically Diseased Lungs Associated with Cystic Fibrosis
por: Melnik, Alexey V., et al.
Publicado: (2019)

Draft Genome Sequences of Two Cystic Fibrosis Strains of Stenotrophomonas maltophilia, AU30115 and AU32848
por: Eckstrom, Korin, et al.
Publicado: (2018)

Modeling the Impact of Antibiotic Exposure on Human Microbiota
por: Zhao, Jiangchao, et al.
Publicado: (2014)

Mechanistic Model of Rothia mucilaginosa Adaptation toward Persistence in the CF Lung, Based on a Genome Reconstructed from Metagenomic Data
por: Lim, Yan Wei, et al.
Publicado: (2013)

Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples
por: Caverly, Lindsay J., et al.
Publicado: (2016)

Impact of the SARS-CoV-2 pandemic on cystic fibrosis centres and care: survey results from US centres
por: Muhlebach, Marianne S., et al.
Publicado: (2021)

Draft Genome Sequences of Seven Pseudomonas fluorescens Subclade III Strains Isolated from Cystic Fibrosis Patients
por: Scales, Brittan S., et al.
Publicado: (2015)

Environmental Pseudomonads Inhibit Cystic Fibrosis Patient-Derived Pseudomonas aeruginosa
por: Chatterjee, Payel, et al.
Publicado: (2016)

Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem
por: Narayanaswamy, Vidya P., et al.
Publicado: (2017)

Parallel Analysis of Cystic Fibrosis Sputum and Saliva Reveals Overlapping Communities and an Opportunity for Sample Decontamination
por: Lu, Junnan, et al.
Publicado: (2020)

In Vitro Activity of a Novel Glycopolymer against Biofilms of Burkholderia cepacia Complex Cystic Fibrosis Clinical Isolates
por: Narayanaswamy, Vidya P., et al.
Publicado: (2019)

Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis
por: Carmody, Lisa A., et al.
Publicado: (2018)

Examining the activity of cefepime-taniborbactam against Burkholderia cepacia complex and Burkholderia gladioli isolated from cystic fibrosis patients in the United States
por: Mojica, Maria F., et al.
Publicado: (2023)

Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients
por: Neerincx, Anne H., et al.
Publicado: (2021)

A putative lateral flagella of the cystic fibrosis pathogen Burkholderia dolosa regulates swimming motility and host cytokine production
por: Roux, Damien, et al.
Publicado: (2018)

Cystic Fibrosis Lung Disease in the Aging Population
por: Künzi, Lisa, et al.
Publicado: (2021)

Neutrophilic proteolysis in the cystic fibrosis lung correlates with a pathogenic microbiome
por: Quinn, Robert A., et al.
Publicado: (2019)

Characterizing Lung Disease in Cystic Fibrosis with Magnetic Resonance Imaging and Airway Physiology
por: Theilmann, Rebecca J., et al.
Publicado: (2016)

A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lung(✩)
por: Sosinski, Lo M., et al.
Publicado: (2022)

Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways
por: Khanolkar, Rutvij A., et al.
Publicado: (2020)

Community analysis and co-occurrence patterns in airway microbial communities during health and disease
por: Einarsson, Gisli G., et al.
Publicado: (2019)

Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis
por: Vieira, Jacob, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8a8hf4asdsot01jsbrjs7alfj4